Device Impact on the Efficacy of Serum Product Study
The goal of this clinical trial is to learn whether combining a beauty device with the test product affects skin parameters in women troubled by wrinkles. It aims to evaluate the impact of the beauty device on the efficacy of the test product. The main questions it aims to answer are:
- Does the combination of the beauty device plus test product achieve better skin improvement compared with using the test product alone?
Researchers will compare beauty device + test product applied to one half of the face and one side of the neck against the test product alone applied to the contralateral half-face and neck, to see whether the beauty device enhances the efficacy of the test product.
Participants will:
- Receive randomized split-face and split-neck treatment during the study
- Attend 10 scheduled study visits
- Undergo standardized image capture, clinical assessment and instrumental skin measurement
調査の概要
状態
条件
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Yanwen Jiang
- 電話番号:+86 13501700841
- メール:jiangyanwen@china-norm.com
研究場所
-
-
Shanghai Municipality
-
Shanghai、Shanghai Municipality、中国
- 募集
- Shanghai China-norm Quality Technical Service Co., Ltd., Shanghai, Shanghai 200072, Shanghai,
-
コンタクト:
- Yanwen Jiang
- 電話番号:+86 13501700841
- メール:jiangyanwen@china-norm.com
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- 1. Chinese female with 25 - 55 years old.
- 2. All skin types, 50% self-declare sensitive skin.
- 3. Self- declare with concerns on facial wrinkle problems.
- 4. The difference in clinical grading between the two sides of the face should be less than one point.
- 5. Presenting with following certain degree skin qualities clinical grading by dermatologist: Skin radiance, brightness, global appearance of fine lines, elasticity, plumpness, skin firmness: 3≤grade≤6 (refer to 0-9 scale); Crow's feet wrinkles: 2≤ grade (Skin Aging Atlas); Underneath eye wrinkle: 2≤ grade (Skin Aging Atlas); Nasolabial folds:2 ≤ grade (Skin Aging Atlas); Ptosis of the lower part of the face 1≤grade (Skin Aging Atlas);
- 6. Did not participate any clinical test or cosmetic product test on skin within 3 months.
- 7. Did not participate any chemical/beauty procedures for previous 6 months.
- 8. No disagreement of dermatologist because of other reasons that exclude the participation of the subject.
- 9. Willing and able to participate as evidenced by signing of informed consent and photo release form.
- 10. Must be willing to comply with all study protocol requirements.
Exclusion Criteria:
- 1. Pregnant or breast-feeding woman or woman planning pregnancy during the study.
- 2. Subject deprived of rights by a court or administrative order.
- 3. Major subject to a guardianship order.
- 4. Subject residing in a health or social care establishment.
- 5. Patient in an emergency setting.
- 6. Subject with a skin disease in the test areas as well as skin allergy (particularly e.g., acne, rosacea, eczema).
- 7. Subject presenting a stable or progressive serious disease (per investigator's assessment).
- 8. Immuno-compromised subject.
- 9. Subject with history of allergy to cosmetic or personal care products or ingredients.
- 10. Subject presenting excessive exposure to sunlight or UV radiation (investigator's assessment).
- 11. Subject regularly practicing aquatic or nautical sports.
- 12. Subject regularly attending a sauna.
- 13. Subject with physical highly sensitive constitution.
- 14. Subject with cardiovascular or circulatory history.
- 15. Subject with a history of skin cancer or malignant melanoma.
- 16. Intake of antihistamines, antibiotics, corticosteroids, non-steroidal anti-inflammatories or immune- suppressants in the last 6 months before study.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Arm 1
Randomly assigned half-face and half-neck receives the beauty device combined with the test product. The study includes short-term on-site application and long-term home-use regimen. |
Short-term: 1.48 g test product applied on half-face & half-neck, massaged by beauty device for about 5 min 50 sec at study site. Long-term: Subjects follow standardized home skincare routine between visits. On-site visits: treatment side receives beauty device and test product. |
|
アクティブコンパレータ:Arm 2
Contralateral half-face and half-neck receives only the test product without the beauty device, as within-subject control. The same home skincare regimen is followed. |
Short-term: 0.45 g test product manually applied on half-face by staff, no beauty device. Long-term: same full-face home skincare routine. On-site visits: only test product is applied on this control side without beauty device treatment. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Dermatologist clinical assessment of skin parameters using modified Griffiths 10-point scale
時間枠:2 weeks before baseline, Baseline, 1 hour and 24 hours after product application, 1 hour after product application at Week 1 visit, 1 hour after product application at Week 2 visit,1 hour after product application at Week 3 visit and Week 4 visit.
|
A dermatologist evaluates skin parameters on the left and right half-face/half-neck separately. Assessments include skin tone, skin quality and wrinkle parameters graded on a 0-9 scale. Half-point (0.5) or incremental values (0.4/0.6) may be used. The rater is blinded to prior scores after baseline. |
2 weeks before baseline, Baseline, 1 hour and 24 hours after product application, 1 hour after product application at Week 1 visit, 1 hour after product application at Week 2 visit,1 hour after product application at Week 3 visit and Week 4 visit.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Stratum corneum hydration measured by Corneometer® CM 825
時間枠:Baseline, Week1 visit, Week2 visit, Week3 visit, Week4 visit
|
Skin hydration is measured bilaterally on cheeks using Corneometer® CM 825 (capacitance method). The mean value of 3 consecutive valid readings is recorded; higher values indicate greater hydration. |
Baseline, Week1 visit, Week2 visit, Week3 visit, Week4 visit
|
|
Transepidermal water loss (TEWL) measured by Vapometer
時間枠:Baseline, Week1 visit, Week2 visit, Week3 visit, Week4 visit
|
TEWL is measured bilaterally on cheeks using Vapometer. One reading is taken per site. Unit: g/m²h; lower values indicate better skin barrier function. |
Baseline, Week1 visit, Week2 visit, Week3 visit, Week4 visit
|
|
wrinkle analysis using Antera 3D
時間枠:Baseline, 1 hour after product application, Week3 (1 hour after product application at Week3 visit), Week4
|
Antera 3D generates 3D colour images of skin surface by analysing shadow and light reflection. Standard wrinkle photographs are captured and analysed. |
Baseline, 1 hour after product application, Week3 (1 hour after product application at Week3 visit), Week4
|
|
Skin texture analysis using VisioScan VC20
時間枠:Baseline, 1 hour and 24 hours after product application, Week1 (visit and 1h post-application), Week2 (visit and 1h post-application), Week3 (visit and 1h post-application), Week4
|
VisioScan VC20 (UV CCD imaging probe) captures skin images on bilateral cheeks and neck. Images are processed and analysed by SELS software to evaluate skin smoothness. |
Baseline, 1 hour and 24 hours after product application, Week1 (visit and 1h post-application), Week2 (visit and 1h post-application), Week3 (visit and 1h post-application), Week4
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
3D facial imaging using Vectera-H2
時間枠:Baseline, 1 hour after product application, Week3 (1 hour after product application at Week3 visit), Week4
|
Handheld Vectera-H2 captures 180° stereophotogrammetric 3D facial images. Assessment endpoint: facial fullness. |
Baseline, 1 hour after product application, Week3 (1 hour after product application at Week3 visit), Week4
|
|
Facial imaging acquisition using VISIA®-CR (Canfield)
時間枠:Baseline, 1 hour and 24 hours after product application, Week1 (visit and 1h post-application), Week2 (visit and 1h post-application), Week3 (visit and 1h post-application), Week4
|
Facial images are captured by trained staff with VISIA®-CR, equipped with multiple light sources (standard, cross-polarized, parallel polarized, oblique, UV). Images are taken from left, central and right views with subject wearing hairnet and eyes closed. |
Baseline, 1 hour and 24 hours after product application, Week1 (visit and 1h post-application), Week2 (visit and 1h post-application), Week3 (visit and 1h post-application), Week4
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- C26005101
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。